Stockscreener 앱 받기
0.5678
10.45%
0.0537
20 20 Biolabs Inc 주식(AIDX)의 최신 뉴스
Form 8K 20/20 BIOLABS For: 19 August By Investing.com - Investing.com Nigeria
20/20 Biolabs adjourns vote on charter amendment, elects directors at annual meeting - Investing.com
20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level - Sahm
20/20 Biolabs Releases Q2 2026 Financial Results - AlphaStreet
20/20 Biolabs Q2 Results: EPS misses, revenue up 36% - scanx.trade
20/20 Biolabs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
20/20 Biolabs, Inc. Common Stock (NASDAQ: AIDX) Stock Price, News & Analysis - kalkine.ca
20/20 Biolabs to host investor webinar; reports best quarterly cancer-test revenue to date - tradingview.com
20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour - Yahoo Finance
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy - The Manila Times
20/20 BioLabs meets potential partners in East Asia - Investing.com
20/20 BioLabs meets potential partners in East Asia By Investing.com - Investing.com Canada
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets - GlobeNewswire
20/20 BioLabs seeks East Asia M&A, JV deals to roll up AI blood test assets - scanx.trade
20/20 Biolabs, Inc. Revenue Breakdown – NASDAQ:AIDX - TradingView
20/20 Biolabs Inc. (AIDX) Slides 4.1% as Stock Tests Key Support at $0.47Gap Up Stocks - dars.gov.et
20/20 Biolabs, Inc. (AIDX) stock price, news, quote and history - Yahoo Finance UK
Rokit Healthcare, US 20/20 BioLabs to Co-Develop AI Multi-Cancer Prediction Platform - Seoul Economic Daily
20/20 BioLabs enters standstill pact on preferred stock - Investing.com
20/20 BioLabs Enters Temporary Standstill Agreement Limiting Series E Preferred Stock Conversions - Quiver Quantitative
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock - The Manila Times
Press Release: 20/20 BioLabs Announces Standstill Agreement With Streeterville Capital Regarding Series E Convertible Preferred Stock - Moomoo
20/20 Biolabs, Inc. Signs Standstill Agreement With Streeterville Capital – SEC 8-K Filing Details (July 2026) - Minichart
20/20 Biolabs Received Notice of Noncompliance - TradingView
20/20 Biolabs (Nasdaq: AIDX) signs standstill as Nasdaq flags bid-price issue - Stock Titan
Why Super Micro Computer Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
What Factors Led to 20/20 Biolabs' Dramatic Stock Collapse - Kavout | AI
20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth - The Manila Times
20/20 BioLabs reports Q2 MCED revenue to be highest to date - Investing.com
20/20 BioLabs highlights OneTest™ strategy for Medicare coverage and reports strong Q2 revenue growth - Pluang
20/20 BioLabs Highlights Investor Webinar Focused on - GlobeNewswire
20/20 BioLabs targets Medicare path as Q2 revenue jumps 30% - scanx.trade
Virax Biolabs | 20-F: Registration statement / Annual report / Transition report - Moomoo
AIDX SEC Filings20/20 Biolabs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
20/20 Biolabs (AIDX) Jumps Nearly 5% as Stock Approaches Key $0.67 ResistanceIchimoku Cloud - dars.gov.et
20/20 Biolabs to present OneTest webinar outlining Medicare pathway, modeling and reimbursement plan - TradingView
OneTest growth vision: 20/20 Biolabs (AIDX) targets Medicare MCED market - Stock Titan
20/20 BioLabs’ Multi-Cancer Early Detection Test Now Available to Evexia Diagnostics' 40,000+ U.S. Practitioners - The National Law Review
20/20 Biolabs Inc. (AIDX) Edges Higher in Low-Price Territory as Support HoldsWyckoff Spring - dars.gov.et
20/20 Biolabs, Inc. Actuals & Estimates (NASDAQ:AIDX) - TradingView
Price to sales forward of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
Price to book forward of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
Price to earnings forward of 20/20 Biolabs, Inc. – NASDAQ:AIDX - TradingView
AIDX | 20/20 Biolabs, Inc. Common Executive Compensation - Quiver Quantitative
Large share authorization and new equity plan up for 20/20 Biolabs (AIDX) vote - Stock Titan
20/20 BioLabs Bets on Radical Transparency with Monthly Investor Calls - BriefGlance
20/20 BioLabs Launches Monthly Investor Webinar Series to Enhance Shareholder Communication - Quiver Quantitative
20/20 BioLabs starts monthly webinars, with a OneTest discount for attendees - Stock Titan
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month - GlobeNewswire
20/20 Biolabs, Inc.(NasdaqCM: AIDX) added to S&P TMI Index - marketscreener.com
AIDX Price Today: 20/20 Biolabs, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Meet Greater Washington's newest publicly traded companiesWashington Business Journal - The Business Journals
AIDX - Finviz
20/20 Biolabs Inc. (AIDX) Surges 13.6%: Breaking Out on Heavy VolumeSentiment Shift - dars.gov.et
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
1.16%
0.26%
자본화:
|
볼륨(24시간):